rs12573077

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004311.4(ARL3):​c.*2021G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.323 in 151,864 control chromosomes in the GnomAD database, including 8,335 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8332 hom., cov: 31)
Exomes 𝑓: 0.56 ( 3 hom. )

Consequence

ARL3
NM_004311.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0470

Publications

23 publications found
Variant links:
Genes affected
ARL3 (HGNC:694): (ADP ribosylation factor like GTPase 3) Enables GDP binding activity; GTP binding activity; and microtubule binding activity. Involved in several processes, including cilium assembly; protein localization to cilium; and small GTPase mediated signal transduction. Acts upstream of or within post-Golgi vesicle-mediated transport. Located in several cellular components, including microtubule cytoskeleton; midbody; and photoreceptor connecting cilium. Implicated in Joubert syndrome and retinitis pigmentosa 83. [provided by Alliance of Genome Resources, Apr 2022]
ARL3 Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 83
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Joubert syndrome 35
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Illumina, Orphanet
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.388 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004311.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARL3
NM_004311.4
MANE Select
c.*2021G>T
3_prime_UTR
Exon 6 of 6NP_004302.1P36405

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARL3
ENST00000260746.6
TSL:1 MANE Select
c.*2021G>T
3_prime_UTR
Exon 6 of 6ENSP00000260746.4P36405
ARL3
ENST00000901818.1
c.*2021G>T
3_prime_UTR
Exon 5 of 5ENSP00000571877.1

Frequencies

GnomAD3 genomes
AF:
0.323
AC:
48964
AN:
151730
Hom.:
8329
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.393
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.258
Gnomad ASJ
AF:
0.329
Gnomad EAS
AF:
0.172
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.331
Gnomad MID
AF:
0.303
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.306
GnomAD4 exome
AF:
0.563
AC:
9
AN:
16
Hom.:
3
Cov.:
0
AF XY:
0.583
AC XY:
7
AN XY:
12
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.563
AC:
9
AN:
16
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.323
AC:
48975
AN:
151848
Hom.:
8332
Cov.:
31
AF XY:
0.317
AC XY:
23514
AN XY:
74196
show subpopulations
African (AFR)
AF:
0.393
AC:
16246
AN:
41372
American (AMR)
AF:
0.258
AC:
3935
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.329
AC:
1141
AN:
3470
East Asian (EAS)
AF:
0.172
AC:
889
AN:
5168
South Asian (SAS)
AF:
0.143
AC:
688
AN:
4816
European-Finnish (FIN)
AF:
0.331
AC:
3473
AN:
10498
Middle Eastern (MID)
AF:
0.301
AC:
88
AN:
292
European-Non Finnish (NFE)
AF:
0.320
AC:
21742
AN:
67934
Other (OTH)
AF:
0.304
AC:
640
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1664
3328
4993
6657
8321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.319
Hom.:
12602
Bravo
AF:
0.322
Asia WGS
AF:
0.160
AC:
555
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
8.7
DANN
Benign
0.69
PhyloP100
-0.047
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12573077; hg19: chr10-104434630; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.